Percent stimulation by insulin was once again markedly reduced in AD compared to controls (Figure 3C; p < 0.001) and significantly improved with simufilam treatment (p < 0.001) to a level close to control on Day 28. This evidence concerns the gene INS and Alzheimer disease.